Contemporary epidemiology and outcomes of invasive fungal infections (IFIs) in solid organ transplant (SOT) recipients are not well described. From March 2004 through September 2007, proven and probable IFIs were prospectively identified in 17 transplant centers in the United States. A total 429 adult SOT recipients with 515 IFIs were identified; 362 patients received a…
Transplant Infectious Disease Template
Write in a clean editor, then format for Transplant Infectious Disease in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Transplant Infectious Disease format
Transplant Infectious Disease is a peer-reviewed journal published by Wiley, covering Cytomegalovirus and herpesvirus research, Antifungal resistance and susceptibility, Fungal Infections and Studies.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Transplant Infectious Disease 12 (3): 45–58.
Formats any DOI in Transplant Infectious Disease style. No sign-up. |
| Publishes research in | Cytomegalovirus and herpesvirus research Antifungal resistance and susceptibility Fungal Infections and Studies Renal Transplantation Outcomes and Treatments Polyomavirus and related diseases |
| ISSN | 1398-2273 |
| Citation impact (2-yr) | 1.6 |
| h-index | 88 |
| i10-index | 1,838 |
| Total citations | 65,702 |
| Article processing charge | $3,550 |
| Top institutions publishing here | Mayo Clinic |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Transplant Infectious Disease per year
Citation impact of Transplant Infectious Disease by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Transplant Infectious Disease
BACKGROUND: Invasive aspergillosis (IA) is associated with significant morbidity and mortality in solid organ transplant recipients but data on the incidence rates stratified by type of solid organ are limited. OBJECTIVE: To describe the attack rates and incidence of IA in solid organ transplant recipients, and the impact of universal Aspergillus prophylaxis (aerosolized amphotericin B…
Opportunistic fungi have emerged during the past decade as important causes of morbidity and mortality in immunocompromised patients. Candida species constitute the third to fourth most common causes of nosocomial blood stream infections, and Aspergillus species have emerged as the most common infectious cause of pneumonic mortality in bone marrow/stem cell transplant recipients. Among HIV-infected…
Human adenovirus (HAdV) infections are increasingly recognized as important pathogens in immunocompromised hosts, especially in patients with severely suppressed T-cell function. The 4th European Conference of Infections in Leukemia (ECIL-4) has developed evidence-based guidelines for diagnosis and management of HAdV infections. The risk for HAdV-associated disease is increased in children, and risk factors for HAdV…
Post-transplant lymphoproliferative disorders (PTLD) are a recognized complication of the immunosuppression required to prevent allograft rejection, occurring in 1-20% of recipients of solid organ transplants. Several factors greatly increase the risk of developing PTLD early post-transplant in any individual recipient. Epstein-Barr virus (EBV) infection is critical in the pathogenesis of the majority of these cases.…